Cargando…

Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G

The irritative effects of preservatives found in ophthalmologic solution, or of antiseptics used for skin disinfection is a consistent problem for the patients. The reduction of the toxic effects of these compounds is desired. Brilliant Blue G (BBG) has shown to meet the expected effect in presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartok, Melinda, Tandon, Rashmi, Alfaro-Espinoza, Gabriela, Ullrich, Matthias S., Gabel, Detlef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553885/
https://www.ncbi.nlm.nih.gov/pubmed/26417355
http://dx.doi.org/10.17179/excli2014-556
_version_ 1782387968566099968
author Bartok, Melinda
Tandon, Rashmi
Alfaro-Espinoza, Gabriela
Ullrich, Matthias S.
Gabel, Detlef
author_facet Bartok, Melinda
Tandon, Rashmi
Alfaro-Espinoza, Gabriela
Ullrich, Matthias S.
Gabel, Detlef
author_sort Bartok, Melinda
collection PubMed
description The irritative effects of preservatives found in ophthalmologic solution, or of antiseptics used for skin disinfection is a consistent problem for the patients. The reduction of the toxic effects of these compounds is desired. Brilliant Blue G (BBG) has shown to meet the expected effect in presence of benzalkonium chloride (BAK), a well known preservative in ophthalmic solutions, and octenidine dihydrochloride (Oct), used as antiseptic in skin and wound disinfection. BBG shows a significant protective effect on human corneal epithelial (HCE) cells against BAK and Oct toxicity, increasing the cell survival up to 51 % at the highest BAK or Oct concentration tested, which is 0.01 %, both at 30 min incubation. Although BBG is described as a P2x7 receptor antagonist, other selective P2x7 receptor antagonists, OxATP (adenosine 5’-triphosphate-2’,3’-dialdehyde) and DPPH (N’-(3,5-dichloropyridin-4-yl)-3-phenylpropanehydrazide), did not reduce the cytotoxicity of neither BAK nor Oct. Therefore we assume that the protective effect of BBG is not due to its action on the P2x7 receptor. Brilliant Blue R (BBR), a dye similar to BBG, was also tested for protective effect on BAK and Oct toxicity. In presence of BAK no significant protective effect was observed. Instead, with Oct a comparable protective effect was seen with that of BBG. To assure that the bacteriostatic effect is not affected by the combinations of BAK/BBG, Oct/BBG and Oct/BBR, bacterial growth inhibition was analyzed on different Gram-negative and Gram-positive bacteria. All combinations of BAK or Oct with BBG hinder growth of Gram-positive bacteria. The combinations of 0.001 % Oct and BBR above 0.025 % do not hinder the growth of B. subtilis. For Gram-negative bacteria, BBG and BBR reduce, but do not abolish, the antimicrobial effect of BAK nor of Oct. In conclusion, the addition of BBG at bacterial inhibitory concentrations is suggested in the ready-to-use ophthalmic preparations and antiseptic solutions.
format Online
Article
Text
id pubmed-4553885
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Leibniz Research Centre for Working Environment and Human Factors
record_format MEDLINE/PubMed
spelling pubmed-45538852015-09-28 Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G Bartok, Melinda Tandon, Rashmi Alfaro-Espinoza, Gabriela Ullrich, Matthias S. Gabel, Detlef EXCLI J Original Article The irritative effects of preservatives found in ophthalmologic solution, or of antiseptics used for skin disinfection is a consistent problem for the patients. The reduction of the toxic effects of these compounds is desired. Brilliant Blue G (BBG) has shown to meet the expected effect in presence of benzalkonium chloride (BAK), a well known preservative in ophthalmic solutions, and octenidine dihydrochloride (Oct), used as antiseptic in skin and wound disinfection. BBG shows a significant protective effect on human corneal epithelial (HCE) cells against BAK and Oct toxicity, increasing the cell survival up to 51 % at the highest BAK or Oct concentration tested, which is 0.01 %, both at 30 min incubation. Although BBG is described as a P2x7 receptor antagonist, other selective P2x7 receptor antagonists, OxATP (adenosine 5’-triphosphate-2’,3’-dialdehyde) and DPPH (N’-(3,5-dichloropyridin-4-yl)-3-phenylpropanehydrazide), did not reduce the cytotoxicity of neither BAK nor Oct. Therefore we assume that the protective effect of BBG is not due to its action on the P2x7 receptor. Brilliant Blue R (BBR), a dye similar to BBG, was also tested for protective effect on BAK and Oct toxicity. In presence of BAK no significant protective effect was observed. Instead, with Oct a comparable protective effect was seen with that of BBG. To assure that the bacteriostatic effect is not affected by the combinations of BAK/BBG, Oct/BBG and Oct/BBR, bacterial growth inhibition was analyzed on different Gram-negative and Gram-positive bacteria. All combinations of BAK or Oct with BBG hinder growth of Gram-positive bacteria. The combinations of 0.001 % Oct and BBR above 0.025 % do not hinder the growth of B. subtilis. For Gram-negative bacteria, BBG and BBR reduce, but do not abolish, the antimicrobial effect of BAK nor of Oct. In conclusion, the addition of BBG at bacterial inhibitory concentrations is suggested in the ready-to-use ophthalmic preparations and antiseptic solutions. Leibniz Research Centre for Working Environment and Human Factors 2015-01-21 /pmc/articles/PMC4553885/ /pubmed/26417355 http://dx.doi.org/10.17179/excli2014-556 Text en Copyright © 2015 Bartok et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.
spellingShingle Original Article
Bartok, Melinda
Tandon, Rashmi
Alfaro-Espinoza, Gabriela
Ullrich, Matthias S.
Gabel, Detlef
Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
title Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
title_full Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
title_fullStr Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
title_full_unstemmed Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
title_short Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
title_sort reduction of cytotoxicity of benzalkonium chloride and octenidine by brilliant blue g
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553885/
https://www.ncbi.nlm.nih.gov/pubmed/26417355
http://dx.doi.org/10.17179/excli2014-556
work_keys_str_mv AT bartokmelinda reductionofcytotoxicityofbenzalkoniumchlorideandoctenidinebybrilliantblueg
AT tandonrashmi reductionofcytotoxicityofbenzalkoniumchlorideandoctenidinebybrilliantblueg
AT alfaroespinozagabriela reductionofcytotoxicityofbenzalkoniumchlorideandoctenidinebybrilliantblueg
AT ullrichmatthiass reductionofcytotoxicityofbenzalkoniumchlorideandoctenidinebybrilliantblueg
AT gabeldetlef reductionofcytotoxicityofbenzalkoniumchlorideandoctenidinebybrilliantblueg